Full text is available at the source.
The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide
How nausea relates to reduced eating and weight loss from injected GLP-1 drugs exendin-4 and liraglutide
AI simplified
Abstract
All doses of exendin-4 that suppress food intake also produce conditioned taste avoidance.
- One dose of liraglutide suppresses food intake without causing conditioned taste avoidance.
- Chronic administration of exendin-4 leads to increased ingestion of nonnutritive substances while maintaining reduced food intake and body weight.
- The pica response from exendin-4 is linked to brain activation rather than vagal pathways.
- Exendin-4 administration to the medial subnucleus of the nucleus tractus solitarius reduces food intake and triggers a pica response, indicating this area may mediate nausea responses.
AI simplified